In This Issue
Build your pharma development and manufacturing knowledge base with the latest whitepapers, application notes, posters, and other educational resources from bio/pharma industry suppliers. |
|
|
|
ADVERTISEMENT
 |
|
FEATURED WHITEPAPER
Renishaw
The stability, bioavailability, and processability of an active pharmaceutical ingredient (API) are key to a candidate molecule’s ability to be developed into a commercially viable product. |
|
|
Manufacturing
 |
Brian Machado, Abbe Haser, Feng Haight, Charlie Martin, and Augie Zhang; Leistritz Extrusion
Various extrusion operating conditions and formulations were used to enhance the solubility and recovery of meloxicam (MLX) in copovidone to near 100% on a counter-rotating twin screw extruder (TSE). |
|
Peter Pöchlauer; Thermo Fisher Scientific
Download this whitepaper to learn how to evaluate whether your API will perform better with batch versus flow chemistry, as this dictates not only the process you will use for scale-up but also the facility and expertise needed to do it successful. |
|
|
|
Analytical
 |
Jennifer S. Chadwick, PhD, Kirtland Poss, MBA, and Shiaw-Lin Wu, PhD; BioAnalytix
Potential for improving identification of successful biologic drugs and de-risking CMC and clinical designs earlier through strategic application of advanced mass spectrometry (MS), specifically by assessing target engagement using hydrogen deuterium exchange (HDX) and native MS analyses to guide biologic development decisions, is discussed. |
|
Ian Olmsted, PhD; CEM
One of the critical parameters in pharmaceutical manufacturing is moisture content. The SMART Q uses patented and proprietary technology to bring moisture test times down significantly without compromising accuracy or precision. |
|
|
|
Quality
 |
Contec, Inc.
There are notable risks associated with using relaunderable mops in a cleanroom environment. Yet, some continue to do so. In this whitepaper, learn how and why you should employ single-use products to improve facility cleanliness. |
|
Alconox, Inc.
The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefits in terms of effectiveness, minimal surface residue, and easier cleaning validation. |
|
|
|
Formulation
 |
CPhI North America
With fewer compounds available, drug developers are using compounds with good therapeutic effects despite bioavailability challenges for patients to dose less frequently and reduce complexity as a major selling point. |
|
|
|
|
|